
ClearPoint Neuro is experiencing a fascinating shift in its corporate dynamics, buoyed by an ownership structure where small investors play a commanding role. A considerable 59% of the company’s shares are held by individual investors, bringing with them a diverse array of perspectives and motivations. This contrasts sharply with the typical scenario where institutional investors hold sway, usually prioritizing stability